Physician profile
Victor Gordon
NPI 1346553781
$1,976.31
in general payments reported to CMS, 2019-2025
20 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $33.08 · 2021: $134 · 2022: $286 · 2023: $473 · 2024: $131 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $970.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $311.13 | 2019-2025 | Arikayce, Brinsupri |
| Pulmonx Corporation | $255.70 | 2022-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Jazz Pharmaceuticals INC. | $188.43 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $185.93 | 2019-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $182.37 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.42 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $94.76 | 2019 | |
| Inspire Medical Systems, INC. | $88.06 | 2023 | Inspire |
| Harmony Biosciences LLC | $73.05 | 2020-2022 | |
| Philips North America LLC | $72.43 | 2019-2025 | Vest Therapy Und |
| Mylan Specialty L.P. | $64.87 | 2019-2024 | Yupelri |
| Ethicon INC. | $62.87 | 2024 | Monarch Platform |
| Electromed, INC. | $48.64 | 2019-2025 | Smartvest |
| Resmed Corp | $47.26 | 2019-2024 | |
| Grifols USA, LLC | $40.22 | 2019-2025 | Prolastin-C Liquid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $32.07 | 2025 | Dupixent |
| Genzyme Corporation | $23.83 | 2019 | |
| Axsome Therapeutics, INC. | $20.81 | 2023 | Sunosi |
| Teva Pharmaceuticals USA, INC. | $18.37 | 2019 | |
| Mallinckrodt Hospital Products INC. | $16.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.